Fig. 2From: Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroidsSubgroup analysisTable 1 Baseline characteristics of Fluticasone/salmeterol and budesonide/formoterol cohort before and after matchingBack to article page